Additionally, PD-1 blockade therapy can be effective in patients with r/r DLBCL after failure of CAR-T therapy who had PD-L1 expression in tumor cells and high PD-1 levels in tumor-infiltrated T-cells [98]. This evidence concerns the gene PDCD1 and diffuse large B-cell lymphoma.